ABSTRACT Extracts of bovine hypothalamus were found to contain a significant level of mitogenic activity when tested in a Swiss 3T3 cell [3HlThd incorporation assay and in a human umbilical vein endot elial cell growth assay. The mitogenic activity responsible for 3T3 cell activity was purified and characterized as a fibroblast growth factor (FGF)like mitogen. Neither the biologically active FGF-like mitogen purified from the hypothalamus extracts nor FGF purified from bovine pituitary glands was mitogenic when added to human endothelial cells in vitro, suggesting the presence of more than one mitogen in the hypothalamic extracts. The 3T3 and endothelial cell biological activities of hypothalamic extracts were both found to be inactivated by trypsin, subtilisin, and heat treatment, but were stable to dialysis. The endothelial cell growth factor activity could be efficiently separated from the FGF activity by gel exclusion chromatography. The endothelial cell mitogen possessed a molecular weigt of approximately 75,000, whereas that of FGF was approximately 15,000:'The endothelial cell growth factor activity was found to be inactivated with reducing agents whereas the 3T3 cell mitogenic activity was stable after incubation with 2-mercaptoethanol. Significant levels of endothelial cell mitogenic activity were also found in extracts of bovine brain and pituitary glands. The vascular endothelium exists as a functional monolayer interface between blood and tissue (1, 2) that has been previously characterized in vivo as a population of cells with a low mitotic index (3). Factors that influence the growth and survival of vascular endothelial cells in vitro have important implications not only in the elucidation of normal and pathological states such as thrombus formation (4), the generation of granulation tissue, wound regeneration (5), and tumor growth (6), but also in providing the necessary in itro systems for the study of these processes (7).
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Previous investigations have shown that human and bovine vascular endothelial cells could be grown and maintained in culture if the cell culture medium was supplemented with high concentrations of bovine brain or pituitary fibroblast growth factor (FGF) (5) . These studies eventually led to the establishment of a bovine vascular endothelial cell line that has a strict requirement for FGF (7) . Additional experiments revealed that the mitogenic effect of FGF in vascular endothelial cell culture can be potentiated by the addition of purified human thrombin (5) . It was suggested that the enhancement of FGF action by thrombin in the vascular endothelial cell system does not proceed through a mechanism involving the proteolytic digestion or modification of FGF, but as a result of an interaction between the vascular endothelial cells and thrombin (5 Preparation of Hypothalamic, Pituitary, and Brain Extracts. The hypothalamic extracts were prepared by homogenization of approximately 370 g of bovine hypothalamus (Pel-Freez) in 500 ml of 0.1 M NaCI at 4VC in a Waring blender for 3-4 min (Collaborative Research, Waltham, MA; CR-ECGS). The homogenate was allowed to stir at 40C for 2 hr, after which the sample was centrifuged at 13,800 X g for 40 min and the supernatant was recovered. The extracts of bovine brain and pituitary glands (Snyder Brothers, Sutton, MA) were prepared in an identical fashion.
The hypothalamic extract was further fractionated with streptomycin sulfate (GIBCO) in order to remove soluble lipid. The supernatant was extracted with 0.5% streptomycin sulfate at pH 7.0 for at least 1 hr. after which the extract was centrifuged at 13,800 X g for 40 min and the supernatant was recovered.
Isolation and Separation of Endothelial Cell Growth Factor From FGF. Bovine pituitary FGF and hypothalamic FGF were both purified by the methods previously described by Gospodarowicz and coworkers (8, 9) . The hypothalamic endothelial cell growth factor activity was separated from the hypothalamic FGF (3T3 cell) activity by chromatography of the hypothalamic extracts on Sephadex G-100. A Sephadex (Pharmacia) G-100 column (5 X 90 cm) was equilibrated in 50 mM Tris-HCI, pH 7.5/0.5 mM EDTA. The sample of hypothalamic extract was applied in a volume of 10 ml and eluted with the equilibration buffer. Fractions (19 ml) were collected and assayed for absorbance at 280 nm. After completion of the chromatography, the protein profile was separated into seven distinct pools, lyophilized, and resuspended in 10 ml of distilled, deionized water. The Sephadex G-100 column was calibrated with proteins of known molecular weight: bovine serum albumin, Mr 67,000 (Sigma); mouse 7S nerve growth factor, Mr 140,000 (10); and 2.5S nerve growth factor, Mr 26,000 (11) .
RESULTS
Presence of Mitogenic Activity in Extracts of Bovine Hypothalamus. To ascertain whether the hypothalamus contained mitogenic components, we prepared water-soluble extracts of the hypothalamus and assayed them for biological activity in two cell culture systems. Incorporation of [3H]thymidine into Swiss albino 3T3 cells in the presence of hypothalamic extract (Fig. 1A) revealed that the extract contained a significant amount of biological activity. In addition, supplementation of human umbilical vein endothelial cells with hypothalamic extract at various dilutions also revealed significant in vttro mitogenic activity (Fig. 1B) . The biological activity of the extract in the 3T3 cell culture assay was present in the range of 15-150 ,ug of protein per ml, whereas the human endothelial cells were active in the range of 150-300 Ag of protein per ml. Extracts prepared from bovine brain and pituitary glands also contained significant levels of human endothelial cell and 3T3 cell mitogenic activity (Fig. 2) .
Characterization of 3T3 and Endothelial Cell Mitogenic Activity. Because FGF, previously purified from brain and pituitary glands (8, 9) , has been characterized as a heat-sensitive and trypsin-labile 3T3 and endothelial cell mitogen (8) , studies were performed to determine whether the mitogenic activity reduced the 3T3 cell culture activity of the extract. Similar results were also obtained with purified bovine pituitary gland FGF (Fig. 3B) , suggesting that the 3T3 cell biological activity of hypothalamic extract possessed FGF or FGF-like properties.
Data obtained from studies using human endothelial cells revealed that the endothelial cell activity of hypothalamic extract was also labile to heat, sensitive to incubation with subtilisin, and resistant to dialysis (Fig. 4A) , suggesting that the mitogenic component of the extract responsible for 3T3 and endothelial cell growth was either FGF or an FGF-like mitogen. The response of human endothelial cell growth in the presence of purified bovine pituitary gland FGF was also studied. We did not observe any significant increase in human endothelial cell growth in the presence of purified FGF at concentrations as high as 1 Atg/ml (Fig. 4A) even though the FGF used in these studies was biologically active in the 3T3 cell microtiter assay (Fig. 4B) . Supplementation of the FGF with human thrombin (1 Aug/ml) also failed to produce an endothelial cell mitogenic response (Fig. 4A) .
Purification of Bovine Hypothalamus FGF. Because it remained a possibility that the human endothelial cell growth-promoting activity of hypothalamic extract may have been due to the presence of a unique form of FGF present in the extract preparations, the hypothalamic FGF was purified by procedures previously described for bovine pituitary FGF (8) . Gel exclusion chromatography of the biological activity of hypothalamic FGF eluted with a molecular weight of approximately 15,000 (Fig. 5A) . Biological assay of the hypothalamic FGF Sephadex G-75 fraction (peak 4) demonstrated that the purified mitogen was active in the low nanogram range (Fig. 5B) . The hypothalamic FGF fraction was also tested for biological activity in the human endothelial cell culture assay. We observed no increase in endothelial cell number in cultures supplemented with either purified hypothalamic FGF or hypothalamic FGF and purified human thrombin (Fig. 4A) .
We were also able to determine that the endothelial cell growth factor activity present in extracts of the hypothalamus is chemically distinct from FGF. Incubation of the hypothalamic extract with 2-mercaptoethanol resulted in the complete loss of endothelial cell mitogenic activity with no effect on the 3T3 cell activity of the hypothalamic preparation (Fig. 6 ). In contrast, both the endothelial cell and 3T3 cell biological activities present in the hypothalamic extract appeared to be susceptible to treatment with 0.1 M acetic acid (Fig. 6 ).
Separation of Endothelial Cell Growth-Promoting Activity from 3T3 Cell Mitogenic Activity in Extracts of Hypothalamus. Attempts were made to separate the endothelial cell growth-promoting activity from the 3T3 cell mitogenic activity present in the hypothalamic extract preparations. Separation was achieved by Sephadex G-100 chromatography of the extract preparation. We observed that the extract eluted from the Sephadex G-100 exclusion column as three distinct protein peaks which were subdivided into a total of seven individual fractions (Fig. 7A) . The biological activity of each fraction was determined in the human endothelial cell assay and the 3T3 microtiter assay (Fig. 7B) . The results revealed that the human endothelial cell growth-promoting activity was associated with a high molecular weight fraction (fraction 3), whereas a majority of the 3T3 cell mitogenic activity was associated with a low molecular weight fraction (fraction 7). The apparent molecular weights of the human endothelial cell and 3T3 cell mitogens were approximately 75,000 and 15,000, respectively.
DISCUSSION
FGF is a well-characterized biological mitogen present in bovine pituitary (8) and brain (9) capable of eliciting a mitogenic response in a wide variety of mesoderm-derived cells in vitro (5) . It has been reported that the addition of purified FGF and human thrombin to cultures of human umbilical endothelial cells can prevent the premature senescence of the endothelial cell cultures and stimulate a high index of mitosis (5) . Repeated attempts to confirm these observations with purified bovine pituitary FGF were not successful. We have consistently observed that the in vitro addition of purified bovine pituitary FGF (1 Mug/ml) to human umbilical vein endothelial cells in the presence and absence of human thrombin (1 Ag/ml) does not elicit a mitogenic response or prevent the precocious senescence of the endothelial cell culture. Similar results have also been reported for primary bovine aortic arch endothelial cells (12) . (9) .
Additional evidence supporting the uniqueness of the human endothelial cell mitogen was obtained from the discriminatory behavior of the human endothelial cell biological activity from the FGF activity by gel exclusion chromatography. It was possible to separate the endothelial cell biological activity present in hypothalamic extracts from the 3T3 cell mitogen by Sephadex G-100 chromatography. The 3T3 cell biological activity eluted with a molecular weight of approximately 75,000. Although the biologically active 3T3 cell fraction was devoid of human endothelial cell activity, the endothelial cell fraction was biologically active in the 3T3 cell assay. The results suggest that, although the mitogen responsible for the growth of human endothelial cells in culture is physically, chemically, and biologically distinct from FGF, there appears to be some biological 3T3 cell activity associated with the biologically active endothelial cell fraction. Thus, the endothelial cell growth factor activity can be interpreted as representing either a macromolecular binding protein-growth factor complex related to FGF or a new and unique endothelial cell growth factor.
